Ribosome Biogenesis and Ageing

Ribosomes translate messenger RNA into protein. Before translation can occur, cells must transcribe and process ribosomal RNA, produce ribosomal proteins, assemble small and large precursor subunits, check their quality, and export them from the nucleus. In eukaryotic cells, many early steps occur in the nucleolus, followed by maturation in the nucleoplasm and cytoplasm. [1]

Who This Is Useful For

This page is for readers who want to understand why the cellular machinery that makes ribosomes appears repeatedly in ageing research, how nucleolar changes relate to protein production, and why reduced ribosome biogenesis can be beneficial in one experimental setting but harmful in another.

What Ribosome Biogenesis Includes

Ribosome production is not a single reaction. RNA polymerase I produces a large precursor ribosomal RNA that is chemically modified, folded, and cleaved; RNA polymerase III produces 5S ribosomal RNA; and RNA polymerase II produces messenger RNAs for ribosomal proteins and assembly factors. These components form precursor 40S and 60S subunits through a sequence of assembly and proofreading steps before becoming translation-competent ribosomes. [1]

Because this pathway connects nutrient-responsive growth programmes with protein production, changes in ribosome biogenesis can alter both cellular resource use and which stress-response programmes are engaged. In budding yeast, for example, selective depletion of 60S subunits extends replicative lifespan partly through increased translation of the stress-responsive transcription factor Gcn4. [4]

Age-Associated Changes Are Not Uniform

Studies do not support one universal trajectory in which ribosome production simply rises or falls in every ageing cell. Human fibroblasts from older donors and cells from people with Hutchinson-Gilford progeria syndrome showed enlarged nucleoli, increased ribosomal RNA production, and elevated protein synthesis. [3] By contrast, ribosome profiling across the lifespan of mice found age-associated translational down-regulation of many transcripts encoding ribosomal proteins and biogenesis machinery in liver and kidney. [6]

Cellular senescence adds another pattern. Senescent human cells generated by several triggers showed reduced ribosome biogenesis together with accumulated ribosomal-RNA precursors and unassembled ribosomal proteins. Experimental depletion of selected biogenesis factors was itself sufficient to promote an Rb-dependent senescence programme. [8] These observations show why measurements of ribosomal RNA, nucleolar size, mature ribosomes, and translation rate should not be treated as interchangeable.

The Nucleolus as an Ageing-Related Readout

In worms, several genetically distinct longevity pathways converged on smaller nucleoli and reduced expression of fibrillarin, ribosomal RNA, and ribosomal proteins. Reducing fibrillarin extended worm lifespan, and nucleolar size among genetically similar individuals predicted lifespan. Smaller nucleoli were also observed in long-lived dietary-restricted flies and in selected long-lived mouse models. [2]

Nucleolar size is nevertheless not a direct meter of translation alone. In engineered budding yeast, reducing nucleolar size extended replicative lifespan without requiring a lower protein-synthesis rate. When nucleoli expanded beyond a threshold, their compartmental properties changed, DNA-repair proteins entered abnormally, and instability at repetitive ribosomal DNA increased. [10] This experiment separates a nucleolar effect on genome maintenance from a simple reduction in ribosome output.

Different Observations, Different Meanings

Evidence for Causality in Model Organisms

Genetic experiments show that ribosome-related changes can influence lifespan rather than merely accompany it. Deleting genes involved in 60S subunit production extended budding-yeast replicative lifespan through a mechanism requiring Gcn4. [4] Longitudinal profiling of ageing yeast also found early disruption in the balance between messenger RNA and proteins belonging to the protein-biogenesis machinery, with these changes predicting broader age-associated loss of protein-complex stoichiometry. [5]

The worm and yeast nucleolar experiments extend the causal evidence beyond total translation: modifying fibrillarin affected worm lifespan, while engineered nucleolar compaction in yeast preserved ribosomal-DNA stability even when protein synthesis was not reduced. [2] [10] Together, these results indicate several possible routes from ribosome biogenesis to ageing rather than one conserved explanation for every organism.

Human Evidence and Its Limits

Human evidence is more associative. In two cohorts of women from Hainan, China, peripheral white-blood-cell transcripts related to ribosomal proteins were lower in long-lived individuals than in comparison groups, and the transcription factor ETS1 was linked experimentally to ribosomal-protein-gene expression in cultured cells. [7] This does not show that reduced ribosome biogenesis caused longevity, applies to men, or occurs in the same way in other tissues.

Fibroblast and progeria studies provide direct cellular measurements but examine cultured cells and a rare premature-ageing disorder. [3] Mouse liver and kidney data reveal in vivo mammalian changes, yet they also demonstrate tissue and age dependence. [6] No current human study establishes one optimal ribosome-biogenesis rate for healthy ageing across tissues and life stages.

Evidence Quality and Interpretation

Confidence is high that ribosome biogenesis is a tightly regulated, multi-step pathway and that its components change during ageing. [1] [3] [6] Confidence is also high that selected genetic perturbations of this machinery can alter lifespan in model organisms. [2] [4] [10]

Confidence is lower about a single direction of change or a universal causal mechanism in human ageing. Increased output, reduced output, and defective processing have each been reported in different systems, while nucleolar changes can affect both protein production and ribosomal-DNA stability. [3] [6] [8] [9] [10]

What This Does Not Mean

• It does not mean that making fewer ribosomes is always beneficial; strong biogenesis defects can impair growth or trigger senescence. [8]
• It does not mean that a large nucleolus proves rapid protein synthesis or biological ageing by itself. [3] [10]
• It does not mean that lower expression of ribosomal-protein genes in blood represents every human tissue. [7]
• It does not mean that lifespan effects in yeast or worms establish a human intervention strategy. [2] [4]

Practical Interpretation Examples

• If nucleoli enlarge with age: examine ribosomal-RNA synthesis, precursor processing, mature-ribosome output, and rDNA integrity before assigning one mechanism. [3] [10]
• If ribosomal transcripts decline: distinguish reduced gene expression from altered translation, cell composition, and loss of functional ribosomes. [6] [7]
• If a biogenesis perturbation extends lifespan: identify whether the effect depends on stress signalling, translation rate, or nucleolar genome stability rather than assuming these routes are equivalent. [4] [10]

Summary

Ribosome biogenesis links nucleolar organization, ribosomal-DNA transcription, RNA processing, protein assembly, cellular growth, and translation. Age-associated changes occur at several of these levels and do not follow one uniform direction. Model-organism experiments establish that selected ribosome and nucleolar perturbations can modify lifespan, whereas human studies mainly identify associations in particular cells or cohorts. The most defensible interpretation is that ribosome biogenesis is one context-dependent component of ageing biology whose effects involve both protein production and broader nucleolar functions. [2] [6] [8] [10]

References

1. Klinge, S., & Woolford, J. L. Jr. "Ribosome assembly coming into focus." Nature Reviews Molecular Cell Biology (2019). https://www.nature.com/articles/s41580-018-0078-y
2. Tiku, V. et al. "Small nucleoli are a cellular hallmark of longevity." Nature Communications (2017). https://www.nature.com/articles/ncomms16083
3. Buchwalter, A., & Hetzer, M. W. "Nucleolar expansion and elevated protein translation in premature aging." Nature Communications (2017). https://www.nature.com/articles/s41467-017-00322-z
4. Steffen, K. K. et al. "Yeast life span extension by depletion of 60S ribosomal subunits is mediated by Gcn4." Cell (2008). https://pmc.ncbi.nlm.nih.gov/articles/PMC2749658/
5. Janssens, G. E. et al. "Protein biogenesis machinery is a driver of replicative aging in yeast." eLife (2015). https://elifesciences.org/articles/08527
6. Anisimova, A. S. et al. "Multifaceted deregulation of gene expression and protein synthesis with age." Proceedings of the National Academy of Sciences (2020). https://pmc.ncbi.nlm.nih.gov/articles/PMC7354943/
7. Xiao, F.-H. et al. "ETS1 acts as a regulator of human healthy aging via decreasing ribosomal activity." Science Advances (2022). https://pmc.ncbi.nlm.nih.gov/articles/PMC9045719/
8. Lessard, F. et al. "Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway." Nature Cell Biology (2018). https://www.nature.com/articles/s41556-018-0127-y
9. Turi, Z., Lacey, M., Mistrik, M., & Moudry, P. "Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging." Aging (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6520011/
10. Gutierrez, J. I., & Tyler, J. K. "A mortality timer based on nucleolar size triggers nucleolar integrity loss and catastrophic genomic instability." Nature Aging (2024). https://www.nature.com/articles/s43587-024-00754-5